Search Results - "Stringer, C A"

Refine Results
  1. 1

    Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting by Gordon, A N, Stringer, C A, Matthews, C M, Willis, D L, Nemunaitis, J

    Published in Journal of clinical oncology (01-05-1997)
    “…To determine the maximum-tolerable dose (MTD) of paclitaxel in a phase I dose-escalation study when combined with cisplatin in patients with advanced ovarian…”
    Get more information
    Journal Article
  2. 2

    Phase I Study of Alternating Doublets of Topotecan/Carboplatin and Paclitaxel/Carboplatin in Patients with Newly Diagnosed, Advanced Ovarian Cancer by Gordon, Alan N., Hancock, Kenneth C., Matthews, Carolyn M., Messing, Mark, Stringer, C.A., Doherty, Mark G., Teneriello, Michael

    Published in Gynecologic oncology (01-04-2002)
    “…Objective. The aim of this study was to evaluate topotecan with carboplatin in an alternating doublet with carboplatin and paclitaxel in first-line ovarian…”
    Get full text
    Journal Article
  3. 3

    Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin by Gershenson, D M, Morris, M, Cangir, A, Kavanagh, J J, Stringer, C A, Edwards, C L, Silva, E G, Wharton, J T

    Published in Journal of clinical oncology (01-04-1990)
    “…Since 1984, we have treated 26 patients with malignant ovarian germ cell tumors with a combination of bleomycin, etoposide (VP-16), and cisplatin (BEP) at The…”
    Get more information
    Journal Article
  4. 4

    Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma by Burke, T W, Gershenson, D M, Morris, M, Stringer, C A, Levenback, C, Tortolero-Luna, G, Baker, V V

    Published in Gynecologic oncology (01-10-1994)
    “…Because extrapelvic failure is common in women with high-risk endometrial carcinoma, the curative impact of adjuvant irradiation is limited. To address the…”
    Get more information
    Journal Article
  5. 5

    Clear cell carcinoma of the ovary: a study of 59 cases by Crozier, M A, Copeland, L J, Silva, E G, Gershenson, D M, Stringer, C A

    Published in Gynecologic oncology (01-11-1989)
    “…Clear cell carcinoma of the ovary accounts for 2 to 3% of all epithelial ovarian neoplasms. Patient profiles, pathological characteristics, and results of…”
    Get more information
    Journal Article
  6. 6

    Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva by Burke, T W, Stringer, C A, Gershenson, D M, Edwards, C L, Morris, M, Wharton, J T

    Published in Gynecologic oncology (01-09-1990)
    “…Limited resection of some vulvar cancers may provide cure rates equivalent to those obtained with radical vulvectomy and bilateral inguinal node dissection…”
    Get more information
    Journal Article
  7. 7

    Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide by Burke, T W, Stringer, C A, Morris, M, Freedman, R S, Gershenson, D M, Kavanagh, J J, Edwards, C L

    Published in Gynecologic oncology (01-03-1991)
    “…Both single-agent cisplatin and the combination of doxorubicin and cyclophosphamide demonstrated moderate activity against endometrial carcinoma in earlier…”
    Get more information
    Journal Article
  8. 8

    Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients by Matthews, C M, Burke, T W, Tornos, C, Eifel, P J, Atkinson, E N, Stringer, C A, Morris, M, Silva, E G

    Published in Gynecologic oncology (01-04-1993)
    “…In order to evaluate clinicopathologic determinants of recurrence in adenocarcinoma of the uterine cervix, a detailed retrospective chart review and complete…”
    Get more information
    Journal Article
  9. 9

    Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysis by Stringer, C A, Gershenson, D M, Burke, T W, Edwards, C L, Gordon, A N, Wharton, J T

    Published in Gynecologic oncology (01-09-1990)
    “…Between October 1985 and January 1989, 33 patients with stage I (31) or clinically occult stage II (2) endometrial cancer at a high risk for recurrence were…”
    Get more information
    Journal Article
  10. 10

    Re-treatment of patients with recurrent epithelial ovarian cancer with cisplatin-based chemotherapy by Gershenson, D M, Kavanagh, J J, Copeland, L J, Stringer, C A, Morris, M, Wharton, J T

    Published in Obstetrics and gynecology (New York. 1953) (01-05-1989)
    “…Nineteen patients with recurrent epithelial ovarian cancer who had responded to initial cisplatin-based combination chemotherapy were re-treated with…”
    Get more information
    Journal Article
  11. 11

    Cisplatin therapy for disseminated mixed mesodermal sarcoma of the uterus by Gershenson, D M, Kavanagh, J J, Copeland, L J, Edwards, C L, Stringer, C A, Wharton, J T

    Published in Journal of clinical oncology (01-04-1987)
    “…Eighteen patients with metastatic mixed mesodermal sarcoma of the uterus received cisplatin therapy at the University of Texas (UT) M.D. Anderson Hospital and…”
    Get more information
    Journal Article
  12. 12

    Recurrent cervical carcinoma after radical hysterectomy by Larson, D M, Copeland, L J, Stringer, C A, Gershenson, D M, Malone, Jr, J M, Edwards, C L

    Published in Gynecologic oncology (01-07-1988)
    “…The characteristics of recurrent carcinoma following radical hysterectomy and pelvic lymphadenectomy for cervical carcinoma are not well known. Disease…”
    Get more information
    Journal Article
  13. 13

    Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide by Gershenson, D M, Copeland, L J, Kavanagh, J J, Stringer, C A, Saul, P B, Wharton, J T

    Published in Obstetrics and gynecology (New York. 1953) (01-11-1987)
    “…From September 1981 until June 1986, eight patients with metastatic ovarian stromal tumors were entered into a prospective phase II study to determine the…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy by Smith, H O, Stringer, C A, Kavanagh, J J, Gershenson, D M, Edwards, C L, Wharton, J T

    Published in Gynecologic oncology (01-01-1993)
    “…Fifty-nine patients with recurrent/persistent, or advanced local/metastatic squamous cell cancer of the cervix were treated with combination chemotherapy…”
    Get more information
    Journal Article
  16. 16

    Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: role of adjuvant radiotherapy by Larson, D M, Stringer, C A, Copeland, L J, Gershenson, D M, Malone, Jr, J M, Rutledge, F N

    Published in Obstetrics and gynecology (New York. 1953) (01-03-1987)
    “…A retrospective review of 194 patients with stage IB cervical carcinoma treated with radical hysterectomy between January 1977 and December 1984 revealed 30…”
    Get more information
    Journal Article
  17. 17

    Endodermal sinus tumor of the ovary associated with pregnancy by Malone, J M, Gershenson, D M, Creasy, R K, Kavanagh, J J, Silva, E G, Stringer, C A

    Published in Obstetrics and gynecology (New York. 1953) (01-09-1986)
    “…The association of endodermal sinus tumor of the ovary with pregnancy is a rare event. Reported is a patient with stage Ic endodermal sinus tumor diagnosed in…”
    Get more information
    Journal Article
  18. 18

    Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide by Gershenson, D M, Copeland, L J, Kavanagh, J J, Cangir, A, Del Junco, G, Saul, P B, Stringer, C A, Freedman, R S, Edwards, C L, Wharton, J T

    Published in Cancer (15-12-1985)
    “…Eighty patients with malignant nondysgerminomatous germ cell tumors of the ovary were treated with the combination of vincristine, dactinomycin, and…”
    Get more information
    Journal Article
  19. 19

    Successful treatment of refractory gestational trophoblastic neoplasm with high-dose etoposide and cyclophosphamide by Collins, Jr, R H, White, C S, Stringer, C A, Fay, J W

    Published in Gynecologic oncology (01-12-1991)
    “…A patient with gestational trophoblastic neoplasm failed treatment with several standard chemotherapy regimens and had progressive disease with development of…”
    Get more information
    Journal Article
  20. 20

    Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatin by Gershenson, D M, Kavanagh, J J, Copeland, L J, Del Junco, G, Cangir, A, Saul, P B, Stringer, C A, Edwards, C L, Wharton, J T

    Published in Cancer (01-05-1986)
    “…Fifteen patients with malignant nondysgerminomatous germ cell tumors of the ovary seen at The University of Texas M. D. Anderson Hospital and Tumor Institute…”
    Get more information
    Journal Article